Patients with chronic granulomatous disease (CGD) have recurrent infections with catalase-producing organisms, particularly staphylococci, that survive within their leukocytes. To be most effective, antibiotics used to treat infections in CGD patients may need to kill both intracellular and extracellular organisms. We studied the ability of certain antibiotics to penetrate normal and CGD neutrophils and to kill intracellular staphylococci. Trimethoprim and clindamycin were concentrated in normal and in CGD neutrophils; maximum cellular-to-extracellular concentration ratios of clindamycin and of trimethoprim were -30 and -4, respectively. In contrast, penicillin was excluded from normal neutrophils. Clindamycin, trimethoprim/sulfamethoxazole, rifampin, and trimethoprim/rifampin significantly reduced the number of viable intracellular staphylococci in normal and CGD neutrophils. After 24 h of incubation in the presence of these antibiotics, the number of viable intracellular staphylococci in normal and CGD neutrophils was similar. In contrast, dicloxacillin, gentamicin, and cephalothin had no significant effect on the number of intracellular staphylococci in normal or CGD neutrophils. Abbreviations C, clindamycin C/E, cellular-to-extracellular concentration ratio cfu, colony forming units CGD, chronic granulomatous disease D, dicloxacillin MBC, minimum bactericidal concentration PMNs, polymorphonuclear leukocytes Rif, rifampin SMZ, sulfamethoxazole TMP, trimethoprim CGD is a clinical syndrome characterized by recurrent infections. PMNs from these patients do not kill phagocytosed microorganisms that produce catalase (1). Consequently, continual antibiotic administration has been employed by some to prevent and to treat chronic and recurrent infection in these patients. Certain investigators have warned that continual antibiotic administration may lead to the selection of more virulent organisms or antibiotic-resistant organisms (2); others have reported beneficial results without recognizable adverse effects (3, 4).
Summary
Patients with chronic granulomatous disease (CGD) have recurrent infections with catalase-producing organisms, particularly staphylococci, that survive within their leukocytes. To be most effective, antibiotics used to treat infections in CGD patients may need to kill both intracellular and extracellular organisms. We studied the ability of certain antibiotics to penetrate normal and CGD neutrophils and to kill intracellular staphylococci. Trimethoprim and clindamycin were concentrated in normal and in CGD neutrophils; maximum cellular-to-extracellular concentration ratios of clindamycin and of trimethoprim were -30 and -4, respectively. In contrast, penicillin was excluded from normal neutrophils. Clindamycin, trimethoprim/sulfamethoxazole, rifampin, and trimethoprim/rifampin significantly reduced the number of viable intracellular staphylococci in normal and CGD neutrophils. After 24 h of incubation in the presence of these antibiotics, the number of viable intracellular staphylococci in normal and CGD neutrophils was similar. In contrast, dicloxacillin, gentamicin, and cephalothin had no significant effect on the number of intracellular staphylococci in normal or CGD neutrophils. Abbreviations C, clindamycin C/E, cellular-to-extracellular concentration ratio cfu, colony forming units CGD, chronic granulomatous disease D, dicloxacillin MBC, minimum bactericidal concentration PMNs, polymorphonuclear leukocytes Rif, rifampin SMZ, sulfamethoxazole TMP, trimethoprim CGD is a clinical syndrome characterized by recurrent infections. PMNs from these patients do not kill phagocytosed microorganisms that produce catalase (1) . Consequently, continual antibiotic administration has been employed by some to prevent and to treat chronic and recurrent infection in these patients. Certain investigators have warned that continual antibiotic administration may lead to the selection of more virulent organisms or antibiotic-resistant organisms (2); others have reported beneficial results without recognizable adverse effects (3, 4) .
In CGD patients, to be effective, antibiotic therapy may need to act both against intracellular and extracellular organisms. Persistence of viable intracellular staphylococci has been suggested as an explanation for treatment failures with penicillins; these antibiotics are hydrophilic and do not penetrate into PMNs (5). We. therefore, studied the penetration and antimicrobial activity of certain lipophilic and hydrophilic antibiotics in CGD and normal PMNs.
MATERIALS AND METHODS
MBC. MBCs were determined by the tube dilution method (6) in Medium 199 (M 199; Grand Island Biological Co., Grand Island, NY), using the same concentration of bacteria and the same culture conditions as were used in the bactericidal assay. Under these conditions, the MBCs of Staph. aureus, strain 502A, were the following: TMP, 1 pg/ml; SMZ, 4 pg/ml; D, 0.4 pg/ml; Rif, 0.2 pg/ml; TMP/SMZ, 0.2515 pglml; TMP/Rif, 0.5/1.0 pg/ ml. The MBCs for the Sudra strain of Staph. azlreus, a recent isolate from a patient with bacteremia, were the following: TMP, 8 pg/ml; SMZ, >80 pg/ml; D, 4 pglml; Rif, 1 pg/ml; TMPISMZ, 4/50 pg/ml; TMP/Rif, 411 pg/ml; C, 1 pg/ml; gentamicin, 1 pg/ ml; and cephalothin, 2 pglml. The antibiotic concentrations used in the bactericidal assays are indicated in the results.
Bactericidal activity against intracellular Staph. aureus. Intracellular killing of Staph. aureus 502A (three experiments) and the Sudra strain of Sraph. aureus (two experiments) by PMNs from CGD and normal subjects were evaluated in parallel. None of the subjects were receiving antibiotics, and all were free of signs or symptoms of infection at the time of the assays. Purified PMNs (>95%) were isolated as previously described (7); viability was >97% by trypan blue dye exclusion. Reaction mixtures (3.5 ml total volume) contained PMNs (6 x 106/ml), 15% human type AB serum stored at -70°C to preserve complement, 25% heat-inactivated pooled human serum, and Staph. aureus (I .2 x lo7 organisms/ml) in M199. The assay was initiated by the addition of organisms to the suspension; immediately after mixing, duplicate 0.1-ml aliquots were removed, diluted initially in 0.9 ml of distilled water and then serially diluted in phosphatebuffered saline with 0.1 % gelatin. Aliquots of these dilutions were cultured on Trypticase soy agar at 37°C for 18-20 h, then viable organisms were enumerated. The remaining 3.4 ml of the reaction mixture was incubated at 37°C in a water bath shaking at 100 rpm; after 30 min this was centrifuged at 125 x g and the PMN pellet was resuspended in MI99 containing 10 units of lysostaphin per ml for 10 min. The PMN pellet was then washed twice in M 199 by centrifugation at 250 x g for 10 min, and resuspended in 3.4 ml of M199. This procedure effectively removed extracellular organisms because ( I ) cultures of the final wash supernatant were sterile and (2) filtration of the PMN pellet through I-p pore size or 2-p pore size filters (Nuclepore Corp., Pleasanton, CA) removed all PMNs (as determined by phasecontrast microscopy) and decreased organisms to an undetectable density (<lo cfu/ml). A second 0.1-ml aliquot of the reaction mixture was added to distilled water, diluted, and cultured. The remaining reaction mixture was then aliquoted into 1-ml volumes containing M 199 alone or M 199 plus one of the antibiotics or antibiotic combinations. The tubes were incubated at 37°C in a water bath shaking at 100 rpm. At 2, 6, and 24 h, an aliquot of the reaction mixture was processed for quantitation of viable PMN-associated organisms.
Certain antibiotics are rapidly degraded in solution; therefore, the bioactivity of each antibiotic in the reaction mixtures after 24 h of incubation was determined by assay against Staph. aureus (Sudra) (6) . Assays for the residual activity included, as controls, supernatants from PMNs in M 199 and M 199 alone to determine if reaction-mixture components inhibited the growth of organisms.
Antibiotic uptake by PMNs. TMP and C penetration into PMNs was assayed by a previously described method (8) . Reaction mixtures containing PMNs in M199 plus [3HzO] (25 mCi/ ml, New England Nuclear, Boston, MA), Naz [35S04] (50 mCi/ mmole, New England Nuclear, Boston, MA), [I4C]-TMP (10 mCi/mmole; Ciba-Geigy, Summit, NJ), or [3H]-C (67.6 mCi/ mmole; Upjohn, Kalamazoo, MI) were incubated for the indicated intervals, layered over inert silicone oil (Versilube, General Electric Co., Schenectady, NY), and centrifuged at 10,000 x g for 2 min. Radioactivity of the PMN pellet and an aliquot of the supernatant were determined in a liquid scintillation spectrometer. The total and extracellular water content of the PMN pellet was determined by relating the cpm in the PMN pellet to the cpm in the known volume of the supernatant for ['H20] and Na?
[35S04], respectively. The extracellular water content was always <lo% of the total water content (normal, 0.42 + 0.27 &lo6 PMN, and CGD, 0.35 + 0.13 p1/106 PMN of the PMN pellet).
The cellular water content of the PMN pellet was determined by subtracting the extracellular water content from the total water content of the PMN pellet. The C/E of TMP and C was determined as previously described (8) . PMN viability was 95% ? 0.7% at 10 min and 88.9% +-2.4% at 24 h.
Statistics. Variance is expressed as standard error. The significance of differences between means was determined by the Student's t test (9) . Figures IA and B . These results were obtained with antibiotic concentrations that were equal to or twice the MBC for the organism and within the range of clinically achievable serum concentrations. Rif, and the combinations TMP/SMZ and TMPJRif reduced the intracellular bacterial density in CGD and normal PMNs more effectively than any of the other drugs evaluated in these studies.
RESULTS

Bactericidal activity of antibiotics against intracellular Staph. aureus. Intracellular killing of the Sudra strain of Staph. aureus by CGD and normal PMNs is shown in
In contrast, dicloxacillin, a hydrophilic antibiotic, had little effect on intracellular bacterial density in either cell type. In two additional experiments, the effects of the hydrophilic antibiotics, cephalothin and gentamicin, were also evaluated. At 2 and 6 h (not shown) and at 24 h, values for cephalothin, gentamicin and no drug were comparable in normal PMNs (5.0 -+ 2.8 x lo4, I .7 + 2.9 x lo4 and 4.1 k 1.6 x lo4 cfu/ml, respectively) and in CGD PMNs (1.1 + 3.0 x lo7, 4.8 k 4.1 x lo6 and 1.6 + 2.1 x lo7 cfu/ml, respectively) whereas results with C were significantly different (P < 0.001) (normal, 2.0 + 1.3 x lo6 cfu/ml and CGD, 4.1 k 3.8 x 10' cfu/ml). Results with strain 502A using antibiotic concentrations equal to or 4-10 times the MBC were comparable; gentamicin, and cephalothin were not tested with this strain. In the assay supernatants, bioactivity of each antibiotic decreased less than 25% after 24 h incubation. PMN viability was 85.6 -t 1.2% after 24 h of incubation; values for control and CGD PMNs were comparable. Under these conditions, in the presence of clinically achievable serum concentrations of C, TMPISMZ, TMP/Rif, or Rif the bactericidal activity of CGD and normal PMNs was comparable at 24 h.
Antibiotic uptake by PMNs. As shown in Figure 2 , TMP and C were rapidly taken up by normal PMNs. Maximum C/E concentration ratios were observed at 10 min. Thereafter, the C/ E concentration ratio of TMP declined up until 120 min (0.44 k 0.1 1) whereas the C/E concentration ratio of C continued to decline throughout the assay and was lowest at 24 h (2.75 + 0.62). This decline was not associated with: ( I ) PMN clumping (10) because by phase contrast microscopy little clumping was observed at any time point, (2) a comparable change in PMN viability, which was 95 ? 1% at 10 min and 89 + 2% at 24 h, and (3) a change in the extracellular or total water content of the PMN pellet (data not shown). Nevertheless, C/E concentration ratios of both drugs were greater at all time points than the C/E concentration ratio of penicillin G, which we have previously reported to be less than 0.2 and stable for up to 120 min of incubation (8) . At the time points studied, penetration of TMP (120 min, C/E = 0.38 + 0.1 1, n = 3) and C (10 min, C/E = 30.9 and 120 min C/E = 8.18 ? 1.24, n = 2) into CGD PMNs was similar to that in normal PMNs.
DISCUSSION
Continuous antibiotic administration to patients with CGD has been advocated since 1967 ( 1); various reports have suggested that nafcillin (3), C (4), sulfonamides (I), and TMP/SMZ (1 1, 12) (Harvey Cohen, M.D., personal communication, 198 1) may be effective in preventing recurrent or recrudescent staphylococcal infections in such patients. Without a controlled clinical trial, as has been done in Chediak-Higashi syndrome ( I 3), the efficacy of such therapy is unclear. Before such a clinical trial is conducted, the antibiotic(s) most likely to be effective may be suggested by in vitro studies of antimicrobial activity in CGD PMNs. The effectiveness of antibiotics for prophylaxis and treatment in CGD patients may be determined in part by their activity against intracellular organisms. If antibiotics that do not enter PMNs are employed, persistence of viable intracellular organisms may contribute to treatment failures in normal patients (5) and in CGD patients.
Our results indicate that C and the combinations TMPJSMZ and TMP/Rif were most effective in killing intracellular Staph. aureus in vitro and that C and TMP penetrated into normal and CGD PMNs and were at least transiently concentrated in these cells. Other studies on the interaction between antibiotics and CGD PMNs have studied either penetration or antimicrobial activity of one or two antibiotics in these cells. The results of these limited studies are compatible with ours: (1) TMP and SMZ penetrate into normal and CGD PMNs (1 1) and, (2) Rif penetrates into normal PMNs (14) and is active against Staph. aureus in normal and CGD PMNs (1 5) .
In the present study, intracellular antimicrobial activity in normal and CGD PMNs of antibiotics from different classes was assessed; this activity was related to penetration into PMNs by certain of these antibiotics. Our results indicate that lipophilic antibiotics, which penetrate PMNs, reduce the bacterial density in CGD PMNs to levels comparable to those in normal PMNs. In contrast, hydrophilic antibiotics, such as dicloxacillin, gentamicin, and cephalothin are not effective against intracellular Staph. aureus. We suggest that this is due, at least in part, to poor penetration of such drugs into PMNs, which we and others have previously observed (8, 11) .
Others have suggested that certain lipophilic antibiotics kill intracellular Staph. aureus by a direct antibacterial effect. Klempner and Styrt (10) demonstrated that C retained its bioactivity intracellularly. Gmiinder and Seger (I I) observed that TMP/ SMZ did not inhibit bacterial catalase, enhance PMN oxidative metabolism, or synergistically affect non-oxygen dependent killing by PMNs. They concluded that its effect was direct and dependent on intracellular penetration. Utilizing a strain of Staph. aurezls that was resistant to C (MBC, 128 ccg/ml) and Rif (MBC, 2 pg/ml), we obtained data that support a similar mechanism of action for C and Rif. With this strain, the intracellular bacterial density was not reduced by concentrations of these drugs that were effective against the 502A and Sudra strains (not shown). Our data suggest that the reduction of intracellular bacterial density by these antibiotics was due to a direct antibacterial effect.
Eradication of intracellular organisms may contribute to resolution of infection and prevention of recrudescent infection in CGD patients and in certain normal patients; thus, C may be a logical drug for the treatment of staphylococcal infections in CGD patients. Because pseudomembranous colitis may complicate C therapy more frequently than it complicates therapy with other drugs, it may be less suitable for continuous treatment. TMP/SMZ or TMPJRif, which also are active against many gram-negative organisms that are the major cause of fatal infections in CGD patients (2), may be more suitable for continuous therapy. Although these data indicate that TMPJSMZ and TMP/ Rif may be suitable for continuous therapy in CGD patients, a prospective, controlled study to analyze the efficacy and potential complications of chronic antibiotic administration in patients with CGD is needed. After 24 h, intravenous fluid therapy produced adequate rehydration as seen from the correction of azotemia, metabolic acidosis, and hypernatremia; only serum creatinine remained elevated. Although cardiac output increased, it did not reach the initial value. Blood flow to most organs was back to normal, but gastrointestinal and particularly renal blood flow remained diminished.
Hemodynamics in Experimental Hypernatremic
appendage. The operation was performed under halothane/02 anesthesia with the animal intubated and ventilated. The atrial catheter went through a subcutaneous dorsal tunnel and the femoral catheters were fixed at the groin in order that the catheters could be manipulated in the unrestrained awake animal. Operation time was on average 240 min. After 3 days of recovery, measurements of blood chemistry and hemodynamics were performed. Sodium, potassium, and calcium were measured with flame photometry; chloride was determined amperometrically. Glucose was measured with the oxidase reaction, creatinine with the Jaffi's reaction, and urea with the urease digestionmethod. Osmolarity was determined by the freezing point depression. Arterial blood gases were measured on an Acid-Base-O2 Microanalyzer, model 939, AVL AG, Schaflhausen, Switzerland, and adjusted to the animals body temperature, which was measured continuously with a rectal probe. Cardiac output was calculated with the dye dilution method using cardiogreen on a Waters XC-Densitometer. Pressure measurements were done Although diagnosis and treatment of hypernatremic dehydra- (9, 15, 17) . lem because these infants are often in a state of pre-shock or In five animals, spheres with a diameter of 50 p and in 15
shock. Little is known about the hemodynamic consequences of animals spheres with a diameter of 15 p were used and each the perfusion of vital organs and the effect of treatment. We injection averaged 37,670 for the 50-and 35 1,000 for the 15-p therefore developed an animal model where hernodynamic spheres. Studies on the use of microspheres in the mini-pig changes and particularly cardiac output, its distribution and showed no difference in extraction for 50-or 15-p spheres for all individual organ blood flow could be investigated. major organs (1 1). The relatively small number of iniected 50-w spheres limited METHODS the accuracy of flow determination &I the adrenal and partly in pancreas, liver artery, and spleen because 400 microspheres are In 20 young 2-month-old mini-pigs, weighing 3.0 kg (2.6-required for a & 10% accuracy and this number could not always 3.66), polyvinyl catheters were inserted into the right femoral be reached (1) . This problem was, however, compensated for by vessels; through a left-sided thoracotomy a thin polyethylene PP an adequate number of animals. 30 catheter was introduced into the left atrium via the left atrial
The gamma activity of the dissected animals was counted on
